Daily Archives: October 10, 2019
Retreatment options for patients who failed DAAs regimens containing NS5A inhibitors: is glecaprevir/pibrentasvir a valid and robust option?
Posted in News
Comments Off on Retreatment options for patients who failed DAAs regimens containing NS5A inhibitors: is glecaprevir/pibrentasvir a valid and robust option?
A dive into the deep heterogeneity of hepatocellular carcinoma
Posted in News
Comments Off on A dive into the deep heterogeneity of hepatocellular carcinoma
Oncofetal SALL4 driven tumorigenesis is highly dependent on oxidative phosphorylation, revealing therapeutic opportunities
Posted in News
Comments Off on Oncofetal SALL4 driven tumorigenesis is highly dependent on oxidative phosphorylation, revealing therapeutic opportunities